Optimal HealthBlog

The Blog of Dr. Henry Sobo

Statin’s Risk of Elevated Liver Enzymes, Rhabdomyolysis, Cancer

Insights From Large Randomized Statin Trials

Molecular Cardiology Research Institute and Division of Cardiology, Department of Medicine, Tufts-New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts. February 21, 2007.

The authors of this study conclude, “The risk of cancer is significantly associated with lower achieved LDL-C levels”. And that “the cardiovascular benefits of low achieved levels of LDL-C may in part be offset by an increased risk of cancer.”

For more information on how to use non-drug methods to lower cholesterol and reduce the risk of cardiovascular disease, call our office.

Download a copy of this original Newsletter